Lotus Pharmaceuticals (LTUS) Stock Price & Analysis

LTUS Stock Chart & Stats

$0.00$0.00(12.50%)

At close: Oct 28 12:34 PM EDT

Day’s Range: $0.00 - $0.01
52-Week Range: $0.00 - $0.01
Previous Close: $0.01
Volume: N/A
Average Volume (3M): 26.93K
Market Cap: $112.66K
Enterprise Value: $109.75B
Total Cash (Recent Filing): $419
Total Debt (Recent Filing): $123.43K
Price to Earnings (P/E): ―
Beta: -2.16
Next Earnings: N/A
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Lotus Pharmaceuticals News

Lenz Therapeutics, Lotus enter license, commercialization agreement for LNZ100

LENZ Therapeutics (LENZ) and Lotus Pharmaceutical (LTUS) announced an exclusive license and commercialization agreement for Lotus to commercialize LNZ100 for the treatment of presbyopia in the Republic of Korea and

1y agoLENZ LTUS

Amarin, Lotus Pharmaceuticals partner to commercialize Vazkepa in Southeast Asia

Amarin Corporation (AMRN) and Lotus Pharmaceuticals (LTUS) announced that the two companies have entered into a long-term exclusive partnership to distribute and commercialize VAZKEPA across 10 countries, including nine in

3y agoAMRN LTUS

Unicycive enters license, development agreement with Lotus in Republic of Korea

Unicycive Therapeutics (UNCY) announced that it has entered into an exclusive license agreement with Lotus Pharmaceutical (LTUS), a leading global pharmaceutical company, for the development and commercialization of Renazorb in

3y agoLTUS UNCY

LTUS FAQ

What was Lotus Pharmaceuticals’s price range in the past 12 months?

Lotus Pharmaceuticals lowest stock price was $0.00 and its highest was $0.01 in the past 12 months.

What is Lotus Pharmaceuticals’s market cap?

Lotus Pharmaceuticals’s market cap is $112.66K.

When is Lotus Pharmaceuticals’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

Is Lotus Pharmaceuticals overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Lotus Pharmaceuticals pay dividends?

Lotus Pharmaceuticals does not currently pay dividends.

What is Lotus Pharmaceuticals’s EPS estimate?

Lotus Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Lotus Pharmaceuticals have?

Lotus Pharmaceuticals has 27,816,000 shares outstanding.

Which hedge fund is a major shareholder of Lotus Pharmaceuticals?

Currently, no hedge funds are holding shares in LTUS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description